Key mechanisms of resistance include tumour-intrinsic factors such as loss of tumour antigens and neoantigen expression, alterations in antigen presentation machinery, activation of oncogenic signalling pathways, impaired interferon (IFN)-γ signalling, and upregulation of alternative immune checkpoints [128,129]. This evidence concerns the gene IFNG and neoplasm.